Key points are not available for this paper at this time.
Although atrial natriuretic peptide levels were significantly increased, candoxatril 200 mg twice daily for 28 days did not produce a clinically relevant fall in blood pressure. Our results cast some doubt upon the role of neutral endopeptidase inhibition in the treatment of unselected hypertensive patients.
Building similarity graph...
Analyzing shared references across papers
Loading...
Journal of Hypertension
Western Infirmary
Add This Paper to Your Research Feed
Any time a new paper drops it will be there.
Bevan et al. (Wed,) studied this question.